Description: - A unique collection of 2240 reprogramming signaling pathway-related bioactive small molecule compounds for high-throughput, high-content screening.- Targets include MEK, TGF-β, GSK3, wnt, etc.- Structural diversity, significant pharmaceutical efficacy, and cell permeability.- Detailed instructions, compound structures, target information, IC50 values, activity descriptions, etc.- Various assays such as NMR, HPLC/LCMS to ensure the correct structure and high purity of the product and reduce false positives.